Anti-SIA7B/ ST6GALNAC2/ SAITL1 functional antibody

Anti-SIA7B/ ST6GALNAC2/ SAITL1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ST6GALNAC2/ST6GALNAC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0490-Ab-1/ GM-Tg-hg-SE0490-Ab-2Anti-Human ST6GALNAC2 monoclonal antibodyHuman
GM-Tg-rg-SE0490-Ab-1/ GM-Tg-rg-SE0490-Ab-2Anti-Rat ST6GALNAC2 monoclonal antibodyRat
GM-Tg-mg-SE0490-Ab-1/ GM-Tg-mg-SE0490-Ab-2Anti-Mouse ST6GALNAC2 monoclonal antibodyMouse
GM-Tg-cynog-SE0490-Ab-1/ GM-Tg-cynog-SE0490-Ab-2Anti-Cynomolgus/ Rhesus macaque ST6GALNAC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0490-Ab-1/ GM-Tg-felg-SE0490-Ab-2Anti-Feline ST6GALNAC2 monoclonal antibodyFeline
GM-Tg-cang-SE0490-Ab-1/ GM-Tg-cang-SE0490-Ab-2Anti-Canine ST6GALNAC2 monoclonal antibodyCanine
GM-Tg-bovg-SE0490-Ab-1/ GM-Tg-bovg-SE0490-Ab-2Anti-Bovine ST6GALNAC2 monoclonal antibodyBovine
GM-Tg-equg-SE0490-Ab-1/ GM-Tg-equg-SE0490-Ab-2Anti-Equine ST6GALNAC2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0490-Ab-1/ GM-Tg-hg-SE0490-Ab-2; GM-Tg-rg-SE0490-Ab-1/ GM-Tg-rg-SE0490-Ab-2;
GM-Tg-mg-SE0490-Ab-1/ GM-Tg-mg-SE0490-Ab-2; GM-Tg-cynog-SE0490-Ab-1/ GM-Tg-cynog-SE0490-Ab-2;
GM-Tg-felg-SE0490-Ab-1/ GM-Tg-felg-SE0490-Ab-2; GM-Tg-cang-SE0490-Ab-1/ GM-Tg-cang-SE0490-Ab-2;
GM-Tg-bovg-SE0490-Ab-1/ GM-Tg-bovg-SE0490-Ab-2; GM-Tg-equg-SE0490-Ab-1/ GM-Tg-equg-SE0490-Ab-2
Products NameAnti-ST6GALNAC2 monoclonal antibody
Formatmab
Target NameST6GALNAC2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ST6GALNAC2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0490-Ag-1Recombinant multi-species SIA7B/ ST6GALNAC2/ SAITL1 protein


    Target information

    Target IDGM-SE0490
    Target NameST6GALNAC2
    Gene ID10610,20446,303692,707237,100049005,101098908,511690,100050960
    Gene Symbol and SynonymsII,SAITL1,SIAT7,SIAT7B,SIATL1,ST6GalNAc,ST6GALNAC2,ST6GalNAII,STHM
    Uniprot AccessionQ9UJ37
    Uniprot Entry NameSIA7B_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000070731
    Target ClassificationN/A

    The target: ST6GALNAC2, gene name: ST6GALNAC2, also named as SAITL1, SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM. ST6GALNAC2 belongs to a family of sialyltransferases that add sialic acids to the nonreducing ends of glycoconjugates. At the cell surface, these modifications have roles in cell-cell and cell-substrate interactions, bacterial adhesion, and protein targeting (Samyn-Petit et al., 2000 [PubMed 10742600]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.